Santen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Santen Pharmaceutical has a total shareholder equity of ¥288.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥409.1B and ¥120.8B respectively. Santen Pharmaceutical's EBIT is ¥51.0B making its interest coverage ratio 333.1. It has cash and short-term investments of ¥84.4B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | 333.1x |
| Cash | JP¥84.44b |
| Equity | JP¥288.25b |
| Total liabilities | JP¥120.83b |
| Total assets | JP¥409.09b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SNPH.Y's short term assets (¥218.5B) exceed its short term liabilities (¥83.9B).
Long Term Liabilities: SNPH.Y's short term assets (¥218.5B) exceed its long term liabilities (¥37.0B).
Debt to Equity History and Analysis
Debt Level: SNPH.Y is debt free.
Reducing Debt: SNPH.Y had no debt 5 years ago.
Debt Coverage: SNPH.Y has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SNPH.Y has no debt, therefore coverage of interest payments is not a concern.